Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Cytotoxic drugs - Biotech, Pharma and Life Science Channel

09:30 EDT 16th April 2014 | BioPortfolio

PubMed Articles [3894 Associated PubMed Articles listed on BioPortfolio]

In brief: Khedzela - a new brand of desvenlafaxine.

New oral anticogulants for acute venous thromboembolism.

Simeprevir (Olysio) for chronic hepatitis c.

Dynamic fluorescent imaging with indocyanine green for monitoring the therapeutic effects of photoimmunotherapy.

A new type of monoclonal antibody (mAb)-based, highly specific phototherapy (photoimmunotherapy; PIT) that uses a near-infrared (NIR) phthalocyanine dye, IRDye700DX (IR700) conjugated with an mAb, has...

Aspirin Desensitization: Useful Treatment for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Aspirin-Exacerbated Respiratory Disease (AERD)?

Aspirin intolerance syndrome is due to disturbances in the arachidonic acid metabolism implicating both the lipoxygenase and cyclooxygenase pathways. This results in imbalances of eicosanoid, leukotri...

An integrated approach for detection and characterization of the trace impurities in levofloxacin using liquid chromatography-tandem mass spectrometry.

Impurity analysis plays an important role to guarantee the quality and safety of pharmaceuticals. However, identification of impurities remains challenging, especially for those unknown or at trace le...

Formulating blackberry leaf mixtures for preparation of infusions with plant derived sources of sweeteners.

Herbal mixtures composed of blackberry leaf and natural sweeteners (dried apples, prunes, figs, raisins, apricots, carrot and sweet potato, stevia leaves and liquorice root) were developed. Their nutr...

Induction Therapy with Combination TNF Inhibitor and Methotrexate in Early Rheumatoid Arthritis.

With the introduction of more objective disease activity measures and the development of biological therapies, there were dramatic changes in the treatment of rheumatoid arthritis (RA). The combinatio...

Platelet function testing in contemporary clinical and interventional practice.

Dual antiplatelet therapy with a combination of aspirin and an inhibitor of the ADP P2Y12 receptor is the recommended treatment for patients with acute coronary syndrome or who are undergoing percutan...

Management of hyponatremia in clinical hepatology practice.

The burden of liver disease continues to increase in the United States, with the epidemics of hepatitis C, alcoholic liver disease, and the coming wave of nonalcoholic fatty liver disease patients all...

News Articles [5148 Associated News Articles listed on BioPortfolio]

Cancer Monthly Warns: Actos Not the Only Drug That May Pose Bladder Cancer Risk

The Japanese drug maker that was recently ordered to pay $6 billion to a man who claimed that his bladder cancer diagnosis was caused by Actos, makes several other drugs with the same active ingredien...

Statins 'may curb prostate cancer'

Cholesterol-lowering statin drugs may curb the spread of prostate cancer by interfering with the ability of tumour cells to squeeze into bones, research has shown.

US Rx drug spending rebounds

Spending on prescription drugs rebounded in 2013, reaching $329.2bn, an increase of 3.2% over 2012 – a year that had experienced the largest ever decline, falling -1.0% – according to IMS...

Global Hypertension Drugs Market 2014-2018

WEST HARTFORD, Conn., April 16, 2014 /PRNewswire-iReach/ -- Global Information Inc. announces the addition of a new market research report "Global Hypertension Drugs Market 2014-2018" at GIIResearch....

Kineta and RLB Holdings announce new joint venture

Kineta, a biotechnology company focused on the development of immune modulating drugs for critical diseases, and RLB Holdings, an investment fund founded by Ray and Lydia Bartoszek, have formed a join...

Thomson Reuters Names 2014 Drugs to Watch

PHILADELPHIA, April 16, 2014 /PRNewswire/ -- The Intellectual Property & Science business of Thomson Reuters, the world's leading provider of intelligent information for businesses and profes...

Express Diagnostics Representatives to Speak at End Violence Against Women International’s 2014 Conference

Express Diagnostics Int’l is honored to be a corporate sponsor for End Violence Against Women International’s 2014 conference April 22-24 in Seattle, Wash., and for the invitation to EDI represent...

Sales of cancer drugs soar once again at Roche

Sales of cancer drugs soar once again at Roche

KRS Global Biotechnology, Inc. Announces FDA Approval of Becoming a Registered Outsourcing Facility (via section 503B); Compounding Quality Act

KRS Global Biotechnology, Inc. a specialty pharmacy preparing drugs no longer commercially available or in short supply announces today that they have become a registered Outsourcing Facility under th...

BioAlliance Pharma says agrees to buy Topotarget

PARIS, April 16 (Reuters) - BioAlliance Pharma said it agreed to buy Scandinavian biopharmaceutical company Topotarget to boost the companies' scale and combine their pipelines of new drugs.

Events [0 Results]

None

Companies [215 Associated Companies listed on BioPortfolio]

Kineta, Inc.

Kineta, Inc. is a Seattle-based privately held biotechnology company specializing in clinical advancement of novel drug candidates derived from leading-edge scientific research. O...

DesignMedix, Inc.

DesignMedix, Inc. was founded in 2008 to develop drugs to overcome drug resistance. The company’s initial focus is on oral drugs to treat malaria, which kills over 600,000 pe...

CogState Ltd

CogState Ltd specializes in the development and commercialization of rapid, computerized tests of cognition (brain function). The tests are sold to pharmaceutical, biotechnology, nutraceutical and...

Cytox Limited

Cytox is a UK company developing products and services for neurodegenerative disorders. The company provides biomarker services to pharmaceutical industry clients conducting clinical trials with drugs...

NeuroVive Pharmaceutical AB

NeuroVive Pharmaceutical AB (www.neurovive.com) is a Swedish drug development company whose primary mission is to develop drugs for the treatment of acute brain injury, reperfusion injury in myocard...

Synthon Chiragenics Corporation

Synthon Chiragenics Corporation is a world-leader in carbohydrate-based chiral technology for pharmaceuticals. Unlike proteins and amino acids that have been the target of biomedical research for deca...

Zarbee’s Naturals

Founded in 2008 by pediatrician Dr. Zak Zarbock, Zarbee’s Naturals manufactures the nation’s #1 natural cough syrup and a complete line of “family-safe” health...

Susavion Biosciences, Inc.

The founders of Susavion Biosciences, Dr. Laura L. Eggink and Dr. J. Kenneth Hoober, developed a platform of novel peptide drugs, which have the potential to provide a breakthroug...

Mallinckrodt plc

Mallinckrodt is a global specialty pharmaceutical business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The c...

Genervon Biopharmaceuticals LLC

Genervon is a privately funded clinical stage biopharmaceutical company in California developing breakthrough multi-target bio-drugs to address the world’s critical unmet...

Clinical Trials [281 Associated Clinical Trials listed on BioPortfolio]

HER2 Imaging Study to Identify HER2 Positive Metastatic Breast Cancer Patient Unlikely to Benefit From T-DM1

T-DM1 , which is a highly innovative but also expensive antiHER2 agent consisting in the coupling of the humanised monoclonal antibody trastuzumab with a cytotoxic agent (maytansine deriva...

Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's Lymphoma

RATIONALE: Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. Donor white blood cells that are treated in the laboratory with Epstei...

Pyroxamide in Treating Patients With Advanced Cancer

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of pyroxamide in...

A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-181)(COMPLETED)

The purpose of this study is to compare the safety and effectiveness of two approved drugs in the treatment of pain following dental surgery.

Rituximab and Gemcitabine for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Rituximab has been demonstrated to sensitize drug-resistant NHL cells to the cytotoxic actions of several chemotherapy agents by enhancing sensitivity of tumor cells to chemotherapy-induce...

The Expression of IL-15 and Its Receptor in Decidua

Human decidual tissue appears to play an important role not only in nurturing the implanted embryos, but also in preventing its rejection by the maternal immune system. Insight into the ma...

Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide

The goal of this study is to determine whether thalidomide can stop the progression of fibrosis in IPF. The primary objective of this study is to determine the safety, feasibility and eff...

Studies of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome

Nitric oxide (NO) plays a pivotal role in maintenance of normal vascular tone. However, in sepsis the excessive production of NO results in myocardial depression, vasoplegia, and cytotoxic...

Study of Satraplatin (JM-216) in Combination With Docetaxel

This is a single center, open-label, non-randomized, Phase I dose finding study of the investigational, oral cytotoxic drug, satraplatin (JM-216), in combination with docetaxel in patients...

Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer

RATIONALE: Androgens can cause the growth of prostate cancer cells. Drugs, such as goserelin, may stop the adrenal glands from making androgens. Drugs used in chemotherapy, such as docetax...

Medical and Biotech [MESH] Definitions

A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

A cytokine which resembles IL-1 structurally and IL-12 functionally. It enhances the cytotoxic activity of NK CELLS and CYTOTOXIC T-LYMPHOCYTES, and appears to play a role both as neuroimmunomodulator and in the induction of mucosal immunity.

Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals.

A critical subpopulation of regulatory T-lymphocytes involved in MHC Class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-LYMPHOCYTES, CYTOTOXIC) and CD8+ suppressor T-lymphocytes.

Drugs used by veterinarians in the treatment of animal diseases. The veterinarian's pharmacological armamentarium is the counterpart of drugs treating human diseases, with dosage and administration adjusted to the size, weight, disease, and idiosyncrasies of the species. In the United States most drugs are subject to federal regulations with special reference to the safety of drugs and residues in edible animal products.

Search BioPortfolio:
Advertisement
review and buy Cytotoxic drugs market research data and corporate reports here

Channels Quicklinks

Advertisement